Teleflex Incorporated

NYSE:TFX

Medical - Instruments & Supplies

Healthcare
$165.85 +0.83%

+$1.04 today

Market cap
$6.58B
Beta
0.82
P/E (TTM)
-5.5
EPS (TTM)
-$22.79
Dividend yield
1.08%
52W Low $100.18High $139.67

Volume 1.16M

Average 0.80M

TFX Total Non-current Liabilities

All obligations due after more than one year.

Teleflex IncorporatedNYSE: TFX

Total Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026

Total non-current liabilities rises 30.9% from a year ago

Total non-current liabilities stood at $3.16B at the end of Q2 FY2026, up 30.9% from a year earlier and up 6.4% from the prior quarter. Over 3 fiscal years it compounded at +9.6% a year.

Context

  • Total non-current liabilities amounted to 46.6% of total assets at the end of Q2 FY2026, up 13.8 pp from a year earlier.
  • Total non-current liabilities increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total non-current liabilities keeps rising in the next quarterly balance sheet after a +30.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$3.16B+6.4% QoQ
Last fiscal yearDec 2025
$3.06B+41.0% YoY
Year agoJun 2025
$2.42B+30.9% since
Total Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+30.9%——
1 year+41.0%——
3-year CAGR+9.6%——
5-year CAGR——
10-year CAGR——

Total Non-current Liabilities history

USD · from the balance sheet

Latest · FY2025
3.06B USD
Year-over-year change
+41.0%
4-year CAGR
+5.9%

Total Non-current Liabilities vs competitors

How TFX compares with its peers on the latest reported figures

  • Peers report in different currencies, so total non-current liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +30.9% is the 6th highest of 11, against a peer median of +33.6%.
  • Total non-current liabilities amounts to 46.6% of total assets for TFX, versus a peer median of 39.9%.
TFX Competitors
Total Non-current Liabilities for TFX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BLCOBausch + Lomb CorporationJun 2026$5.53B USD+0.7%+26.7%39.9%
TFXTeleflex IncorporatedJun 2026$3.16B USD+30.9%+9.6%46.6%
PTCTPTC Therapeutics, Inc.Jun 2026$2.64B USD+19.5%+9.1%81.4%
ALKSAlkermes plcSep 2026$1.92B USD+1476.5%-26.5%43.3%
ARWRArrowhead Pharmaceuticals, Inc.Sep 2026$1.38B USD+100.5%+54.5%79.2%
MMSIMerit Medical Systems, Inc.Sep 2026$915.27M USD+5.1%+42.3%—
CRSPCRISPR Therapeutics AGSep 2026$767.38M USD+264.8%-7.6%30.0%
TGTXTG Therapeutics, Inc.Sep 2026$759.6M USD+191.0%+47.3%47.7%
STVNStevanato Group S.p.A.Jun 2026€490.64M EUR+4.0%+37.3%18.7%
PCVXVaxcyte, Inc.Jun 2026$108.94M USD+37.0%+134.2%3.5%
KRYSKrystal Biotech, Inc.Jun 2026$14.13M USD+30.2%+15.3%0.9%
Peer median (excluding TFX) —+33.6%+32.0%39.9%

Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents445.08M292.03M222.85M290.19M393.26M
Short-term Investments00015.97M0
Net Receivables383.57M408.83M443.47M459.5M345.58M
Inventory477.64M578.51M626.22M600.13M404.4M
Other Current Assets117.28M125.08M107.47M101.88M775.53M
Total Current Assets1.43B1.41B1.41B1.47B1.94B
Property, Plant & Equipment (Net)573.41M578.42M603.43M611.76M590.1M
Goodwill2.5B2.54B2.91B2.63B2.31B
Intangible Assets2.29B2.31B2.5B2.27B1.52B
Long-term Investments011.91M0011.19M
Tax Assets6.82M6.4M6.75M11.37M12.59M
Other Non-current Assets69.1M77.46M98.94M102.62M565.82M
Total Non-current Assets5.44B5.52B6.13B5.63B5.01B
Total Assets6.87B6.93B7.53B7.1B6.95B
Account Payables118.24M126.81M132.25M141.03M130.2M
Short-term Debt110M87.5M87.5M100M100M
Tax Payables83.94M24.74M41.45M41.32M18.79M
Deferred Revenue00000
Other Current Liabilities55.63M63.38M46.55M68.54M388.27M
Total Current Liabilities680.12M581.49M606.75M649.36M762.03M
Long-term Debt1.74B1.62B1.73B1.56B2.54B
Deferred Tax Liabilities370.12M388.89M456.08M391.07M183.75M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities210.6M191.26M189.86M124.32M251.04M
Total Non-current Liabilities2.44B2.32B2.48B2.17B3.06B
Total Liabilities3.12B2.91B3.09B2.82B3.82B
Common Stock47.93M47.96M48.05M48.1M48.2M
Retained Earnings3.52B3.82B4.11B4.12B3.15B
Accumulated OCI(346.96M)(403.52M)(314.41M)(316.67M)(239.47M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity3.75B4.02B4.44B4.28B3.12B
Total Debt1.97B1.83B1.93B1.76B2.73B
Net Debt1.52B1.54B1.7B1.46B2.33B

Teleflex Incorporated

NYSE:TFX

Intrinsic Alpha fair value

Locked

Current Price

$165.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.